| WGM | Name: | (3S)-1-(3-fluoropyridin-2-yl)-4,4-dimethylpyrrolidin-3-ol | Formula: | C11 H15 F N2 O | SMILES: | n1cccc(c1N2CC(O)C(C)(C2)C)F | InChi: | InChI=1S/C11H15FN2O/c1-11(2)7-14(6-9(11)15)10-8(12)4-3-5-13-10/h3-5,9,15H,6-7H2,1-2H3/t9-/m1/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | (3S)-1-(3-fluoropyridin-2-yl)-4,4-dimethylpyrrolidin-3-ol |
|
| WGS | Name: | 3-fluoro-N-[(oxan-4-yl)methyl]pyridin-2-amine | Formula: | C11 H15 F N2 O | SMILES: | N(c1c(F)cccn1)CC2CCOCC2 | InChi: | InChI=1S/C11H15FN2O/c12-10-2-1-5-13-11(10)14-8-9-3-6-15-7-4-9/h1-2,5,9H,3-4,6-8H2,(H,13,14) | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 3-fluoro-N-[(oxan-4-yl)methyl]pyridin-2-amine |
|
| WGV | Name: | 1-(3-phenylprop-2-yn-1-yl)piperidine | Formula: | C14 H17 N | SMILES: | c1ccccc1C#CCN2CCCCC2 | InChi: | InChI=1S/C14H17N/c1-3-8-14(9-4-1)10-7-13-15-11-5-2-6-12-15/h1,3-4,8-9H,2,5-6,11-13H2 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 1-(3-phenylprop-2-yn-1-yl)piperidine |
|
| WGY | Name: | N-(4-sulfamoylphenyl)propanamide | Formula: | C9 H12 N2 O3 S | SMILES: | NS(c1ccc(cc1)NC(=O)CC)(=O)=O | InChi: | InChI=1S/C9H12N2O3S/c1-2-9(12)11-7-3-5-8(6-4-7)15(10,13)14/h3-6H,2H2,1H3,(H,11,12)(H2,10,13,14) | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | N-(4-sulfamoylphenyl)propanamide |
|
| WH1 | Name: | N-methyl-N-[2-(pyridin-2-yl)ethyl]benzamide | Formula: | C15 H16 N2 O | SMILES: | n1c(cccc1)CCN(C(=O)c2ccccc2)C | InChi: | InChI=1S/C15H16N2O/c1-17(12-10-14-9-5-6-11-16-14)15(18)13-7-3-2-4-8-13/h2-9,11H,10,12H2,1H3 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | N-methyl-N-[2-(pyridin-2-yl)ethyl]benzamide |
|
| WH7 | Name: | (2R)-1-{[(2,6-dichlorophenyl)methyl]amino}propan-2-ol | Formula: | C10 H13 Cl2 N O | SMILES: | c1(c(cccc1Cl)Cl)CNCC(C)O | InChi: | InChI=1S/C10H13Cl2NO/c1-7(14)5-13-6-8-9(11)3-2-4-10(8)12/h2-4,7,13-14H,5-6H2,1H3/t7-/m1/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | (2R)-1-{[(2,6-dichlorophenyl)methyl]amino}propan-2-ol |
|
| WHD | Name: | 4-({[(4-fluorophenyl)methyl]amino}methyl)benzonitrile | Formula: | C15 H13 F N2 | SMILES: | N#Cc2ccc(CNCc1ccc(cc1)F)cc2 | InChi: | InChI=1S/C15H13FN2/c16-15-7-5-14(6-8-15)11-18-10-13-3-1-12(9-17)2-4-13/h1-8,18H,10-11H2 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 4-({[(4-fluorophenyl)methyl]amino}methyl)benzonitrile |
|
| WHM | Name: | 2-[(3-fluorophenyl)methyl]-1lambda~6~,2-thiazolidine-1,1-dione | Formula: | C10 H12 F N O2 S | SMILES: | c2(CN1CCCS1(=O)=O)cccc(c2)F | InChi: | InChI=1S/C10H12FNO2S/c11-10-4-1-3-9(7-10)8-12-5-2-6-15(12,13)14/h1,3-4,7H,2,5-6,8H2 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 2-[(3-fluorophenyl)methyl]-1lambda~6~,2-thiazolidine-1,1-dione |
|
| WHP | Name: | N-[(1R)-1-(2-chlorophenyl)ethyl]methanesulfonamide | Formula: | C9 H12 Cl N O2 S | SMILES: | c1cccc(Cl)c1C(NS(=O)(C)=O)C | InChi: | InChI=1S/C9H12ClNO2S/c1-7(11-14(2,12)13)8-5-3-4-6-9(8)10/h3-7,11H,1-2H3/t7-/m1/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | N-[(1R)-1-(2-chlorophenyl)ethyl]methanesulfonamide |
|
| C5F | Name: | 2-{4-[(1S)-2,2-dichlorocyclopropyl]phenoxy}-2-methylpropanoic acid | Formula: | C13 H14 Cl2 O3 | SMILES: | C1(C(Cl)(C1)Cl)c2ccc(cc2)OC(C(=O)O)(C)C | InChi: | InChI=1S/C13H14Cl2O3/c1-12(2,11(16)17)18-9-5-3-8(4-6-9)10-7-13(10,14)15/h3-6,10H,7H2,1-2H3,(H,16,17)/t10-/m0/s1 | Definition date: | 2019-01-23 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 2-{4-[(1S)-2,2-dichlorocyclopropyl]phenoxy}-2-methylpropanoic acid |
|
| WJG | Name: | (S)-1-(4-methoxyphenyl)-1-phenylmethanamine | Formula: | C14 H15 N O | SMILES: | c2(C(N)c1ccccc1)ccc(OC)cc2 | InChi: | InChI=1S/C14H15NO/c1-16-13-9-7-12(8-10-13)14(15)11-5-3-2-4-6-11/h2-10,14H,15H2,1H3 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | (S)-1-(4-methoxyphenyl)-1-phenylmethanamine |
|
| Q52 | Name: | ~{N}-[(4-chlorophenyl)methyl]-1-[2-(6-methoxy-1,5-naphthyridin-4-yl)ethyl]piperidin-4-amine | Formula: | C23 H27 Cl N4 O | SMILES: | COc1ccc2nccc(CCN3CCC(CC3)NCc4ccc(Cl)cc4)c2n1 | InChi: | InChI=1S/C23H27ClN4O/c1-29-22-7-6-21-23(27-22)18(8-12-25-21)9-13-28-14-10-20(11-15-28)26-16-17-2-4-19(24)5-3-17/h2-8,12,20,26H,9-11,13-16H2,1H3 | Definition date: | 2020-05-13 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | ~{N}-[(4-chlorophenyl)methyl]-1-[2-(6-methoxy-1,5-naphthyridin-4-yl)ethyl]piperidin-4-amine |
|
| QKJ | Name: | 3-(3-{3-[(2,4-diamino-6-ethylpyrimidin-5-yl)oxy]propoxy}phenyl)propanoic acid | Formula: | C18 H24 N4 O4 | SMILES: | c1ccc(CCC(=O)O)cc1OCCCOc2c(CC)nc(nc2N)N | InChi: | InChI=1S/C18H24N4O4/c1-2-14-16(17(19)22-18(20)21-14)26-10-4-9-25-13-6-3-5-12(11-13)7-8-15(23)24/h3,5-6,11H,2,4,7-10H2,1H3,(H,23,24)(H4,19,20,21,22) | Definition date: | 2019-11-06 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 3-(3-{3-[(2,4-diamino-6-ethylpyrimidin-5-yl)oxy]propoxy}phenyl)propanoic acid |
|
| CD0 | Name: | 2-[(1R,2R,5S)-5-methyl-2-(prop-1-en-2-yl)cyclohexyl]-5-pentylbenzene-1,3-diol | Formula: | C21 H32 O2 | SMILES: | c1(c(c(O)cc(c1)CCCCC)C2C(CCC(C2)C)/C(C)=C)O | InChi: | InChI=1S/C21H32O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h12-13,15,17-18,22-23H,2,5-11H2,1,3-4H3/t15-,17-,18+/m0/s1 | Definition date: | 2018-05-09 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 2-[(1R,2R,5S)-5-methyl-2-(prop-1-en-2-yl)cyclohexyl]-5-pentylbenzene-1,3-diol |
|
| NQD | Name: | (2Z,6E,10E)-13-[(2R)-6-hydroxy-2,8-dimethyl-3,4-dihydro-2H-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-2,6,10-trienoic acid | Formula: | C27 H38 O4 | SMILES: | C(CC(=CCCC2(C)CCc1cc(cc(c1O2)C)O)C)[C@H]=C(C)CCC=C(/C(=O)O)C | InChi: | InChI=1S/C27H38O4/c1-19(11-7-13-21(3)26(29)30)9-6-10-20(2)12-8-15-27(5)16-14-23-18-24(28)17-22(4)25(23)31-27/h9,12-13,17-18,28H,6-8,10-11,14-16H2,1-5H3,(H,29,30)/b19-9+,20-12+,21-13-/t27-/m1/s1 | Synonyms: | garcinoic acid | Definition date: | 2019-05-23 | Last modified: | 2020-11-06 | Release date: | 2020-04-01 | Identifier: | (2Z,6E,10E)-13-[(2R)-6-hydroxy-2,8-dimethyl-3,4-dihydro-2H-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-2,6,10-trienoic acid |
|
| RFT | Name: | butyl 1-{[2-(2,5-dioxopyrrolidin-1-yl)ethyl]amino}-2-methyl-1-oxopropan-2-yl carbonotrithioate | Formula: | C15 H24 N2 O3 S3 | SMILES: | C(C(SC(SCCCC)=S)(C)C)(NCCN1C(CCC1=O)=O)=O | InChi: | InChI=1S/C15H24N2O3S3/c1-4-5-10-22-14(21)23-15(2,3)13(20)16-8-9-17-11(18)6-7-12(17)19/h4-10H2,1-3H3,(H,16,20) | Definition date: | 2020-05-13 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | butyl 1-{[2-(2,5-dioxopyrrolidin-1-yl)ethyl]amino}-2-methyl-1-oxopropan-2-yl carbonotrithioate |
|
| RH8 | Name: | ~{N}-[3-fluoranyl-4-(4-methylpiperazin-1-yl)phenyl]-4-pyrazolo[1,5-b]pyridazin-3-yl-pyrimidin-2-amine | Formula: | C21 H21 F N8 | SMILES: | CN1CCN(CC1)c2ccc(Nc3nccc(n3)c4cnn5ncccc45)cc2F | InChi: | InChI=1S/C21H21FN8/c1-28-9-11-29(12-10-28)20-5-4-15(13-17(20)22)26-21-23-8-6-18(27-21)16-14-25-30-19(16)3-2-7-24-30/h2-8,13-14H,9-12H2,1H3,(H,23,26,27) | Definition date: | 2020-09-29 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | ~{N}-[3-fluoranyl-4-(4-methylpiperazin-1-yl)phenyl]-4-pyrazolo[1,5-b]pyridazin-3-yl-pyrimidin-2-amine |
|
| QR2 | Name: | 5-[4-chloranyl-3-(trifluoromethyl)phenyl]-3~{H}-1,3,4-oxadiazol-2-one | Formula: | C9 H4 Cl F3 N2 O2 | SMILES: | FC(F)(F)c1cc(ccc1Cl)C2=NNC(=O)O2 | InChi: | InChI=1S/C9H4ClF3N2O2/c10-6-2-1-4(3-5(6)9(11,12)13)7-14-15-8(16)17-7/h1-3H,(H,15,16) | Definition date: | 2020-07-24 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 5-[4-chloranyl-3-(trifluoromethyl)phenyl]-3~{H}-1,3,4-oxadiazol-2-one |
|
| E0O | Name: | 2-(4-chloranylphenoxy)-2-methyl-propanoic acid | Formula: | C10 H11 Cl O3 | SMILES: | CC(C)(Oc1ccc(Cl)cc1)C(O)=O | InChi: | InChI=1S/C10H11ClO3/c1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h3-6H,1-2H3,(H,12,13) | Definition date: | 2019-09-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 2-(4-chloranylphenoxy)-2-methyl-propanoic acid |
|
| EA6 | Name: | 1-[3-(2-chloranyl-4-fluoranyl-phenoxy)propoxy]-6,6-dimethyl-1,3,5-triazine-2,4-diamine | Formula: | C14 H19 Cl F N5 O2 | SMILES: | CC1(C)N=C(N)N=C(N)N1OCCCOc2ccc(F)cc2Cl | InChi: | InChI=1S/C14H19ClFN5O2/c1-14(2)20-12(17)19-13(18)21(14)23-7-3-6-22-11-5-4-9(16)8-10(11)15/h4-5,8H,3,6-7H2,1-2H3,(H4,17,18,19,20) | Definition date: | 2019-11-28 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 1-[3-(2-chloranyl-4-fluoranyl-phenoxy)propoxy]-6,6-dimethyl-1,3,5-triazine-2,4-diamine |
|
| EWL | Name: | 6-azanyl-2-butoxy-9-(phenylmethyl)-7H-purin-8-one | Formula: | C16 H19 N5 O2 | SMILES: | CCCCOc1nc(N)c2NC(=O)N(Cc3ccccc3)c2n1 | InChi: | InChI=1S/C16H19N5O2/c1-2-3-9-23-15-19-13(17)12-14(20-15)21(16(22)18-12)10-11-7-5-4-6-8-11/h4-8H,2-3,9-10H2,1H3,(H,18,22)(H2,17,19,20) | Definition date: | 2020-02-13 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 6-azanyl-2-butoxy-9-(phenylmethyl)-7~{H}-purin-8-one |
|
| EWR | Name: | (2S)-2-ethoxy-3-[4-[2-[2-methyl-5-(4-methylsulfanylphenyl)pyrrol-1-yl]ethoxy]phenyl]propanoic acid | Formula: | C25 H29 N O4 S | SMILES: | CCO[CH](Cc1ccc(OCCn2c(C)ccc2c3ccc(SC)cc3)cc1)C(O)=O | InChi: | InChI=1S/C25H29NO4S/c1-4-29-24(25(27)28)17-19-6-10-21(11-7-19)30-16-15-26-18(2)5-14-23(26)20-8-12-22(31-3)13-9-20/h5-14,24H,4,15-17H2,1-3H3,(H,27,28)/t24-/m0/s1 | Definition date: | 2020-02-13 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | (2~{S})-2-ethoxy-3-[4-[2-[2-methyl-5-(4-methylsulfanylphenyl)pyrrol-1-yl]ethoxy]phenyl]propanoic acid |
|
| EWU | Name: | 6-azanyl-2-(2-methoxyethoxy)-9-(phenylmethyl)-7H-purin-8-one | Formula: | C15 H17 N5 O3 | SMILES: | COCCOc1nc(N)c2NC(=O)N(Cc3ccccc3)c2n1 | InChi: | InChI=1S/C15H17N5O3/c1-22-7-8-23-14-18-12(16)11-13(19-14)20(15(21)17-11)9-10-5-3-2-4-6-10/h2-6H,7-9H2,1H3,(H,17,21)(H2,16,18,19) | Definition date: | 2020-02-13 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 6-azanyl-2-(2-methoxyethoxy)-9-(phenylmethyl)-7~{H}-purin-8-one |
|
| EWX | Name: | 6-azanyl-2-(2-methoxyethoxy)-9-(pyridin-3-ylmethyl)-7H-purin-8-one | Formula: | C14 H16 N6 O3 | SMILES: | COCCOc1nc(N)c2NC(=O)N(Cc3cccnc3)c2n1 | InChi: | InChI=1S/C14H16N6O3/c1-22-5-6-23-13-18-11(15)10-12(19-13)20(14(21)17-10)8-9-3-2-4-16-7-9/h2-4,7H,5-6,8H2,1H3,(H,17,21)(H2,15,18,19) | Definition date: | 2020-02-13 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 6-azanyl-2-(2-methoxyethoxy)-9-(pyridin-3-ylmethyl)-7~{H}-purin-8-one |
|
| EX0 | Name: | 2-ethoxy-8-(5-fluoranylpyridin-3-yl)-9-[[4-[[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]methyl]purin-6-amine | Formula: | C26 H29 F N8 O | SMILES: | CCOc1nc(N)c2nc(n(Cc3ccc(CN4C[CH]5C[CH]4CN5C)cc3)c2n1)c6cncc(F)c6 | InChi: | InChI=1S/C26H29FN8O/c1-3-36-26-31-23(28)22-25(32-26)35(24(30-22)18-8-19(27)11-29-10-18)13-17-6-4-16(5-7-17)12-34-15-20-9-21(34)14-33(20)2/h4-8,10-11,20-21H,3,9,12-15H2,1-2H3,(H2,28,31,32)/t20-,21-/m0/s1 | Definition date: | 2020-02-13 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 2-ethoxy-8-(5-fluoranylpyridin-3-yl)-9-[[4-[[(1~{S},4~{S})-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]methyl]purin-6-amine |
|